Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Name: Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
License: Public Domain

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

ClinicalTrials.gov · Datasets · License: Public Domain

carcinoma, intrahepatic cholangiocarcinoma, gallbladder cancer, surufatinib, angiogenesis inhibitors, tislelizumab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201769
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.